Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer

作者：Jennifer J. Knox, Grainne M. O’Kane, Daniel A. King, Daniel A. Laheru, Amber N. Habowski, Kenneth H. Yu, Kimberly Perez, Andrew J. Aguirre, Zachary Coyne, Harry Harvey, Ronan Andrew McLaughlin, Raymond Jang, Robert C. Grant, Elena Elimova, Daniel J. Renouf, Sandra E. Fischer, Kai Duan, Stephanie Ramotar, Gun Ho Jang, Amy X. Zhang, Craig Devoe, Harshabad Singh, Michael J. Pishvaian, Fieke E. M. Froeling, Muhammad Wasif Saif, Eileen M. O’Reilly, Erica S. Tsang, Brian M. Wolpin, Julie M. Wilson, Anna Dodd, Trevor J. Pugh, Xiang Y. Ye, Steven Gallinger, David A. Tuveson, Faiyaz Notta, Elizabeth M. Jaffee · 发表于：Journal of Clinical Oncology · 年份：2025 · DOI：10.1200/jco-25-02195 · 被引用次数：3 · 研究领域：Cancer Genomics and Diagnostics、Cancer Treatment and Pharmacology、Pancreatic and Hepatic Oncology Research